Katsuyoshi Hashine

Summary

Affiliation: National Shikoku Cancer Center
Country: Japan

Publications

  1. ncbi request reprint Health-related quality of life and treatment outcomes for men with prostate cancer treated by combined external-beam radiotherapy and hormone therapy
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, 13 Horinouchi, Matsuyama, 790 0007, Japan
    Int J Clin Oncol 10:45-50. 2005
  2. doi request reprint Correlation between cancer location and oncological outcome after radical prostatectomy
    Katsuyoshi Hashine
    Department of Urology, Section of Cancer Prevention and Epidemiology, Clinical Research Center, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Int J Urol 19:855-60. 2012
  3. doi request reprint Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
    Int J Urol 18:813-9. 2011
  4. doi request reprint Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomy
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 41:571-6. 2011
  5. pmc Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:502-8. 2009
  6. doi request reprint Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:381-6. 2009
  7. doi request reprint A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer
    Katsuyoshi Hashine
    National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 38:480-5. 2008
  8. doi request reprint Health-related quality of life after bladder preservation therapy for muscle invasive bladder cancer
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Int J Urol 15:403-6. 2008
  9. ncbi request reprint Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama City, Ehime 790 0007, Japan
    Jpn J Clin Oncol 35:655-9. 2005
  10. doi request reprint Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience
    Noriyoshi Miura
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Jpn J Clin Oncol 40:1092-8. 2010

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Health-related quality of life and treatment outcomes for men with prostate cancer treated by combined external-beam radiotherapy and hormone therapy
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, 13 Horinouchi, Matsuyama, 790 0007, Japan
    Int J Clin Oncol 10:45-50. 2005
    ..Health-related quality of life (HR-QOL) is important when considering the treatment options for prostate cancer...
  2. doi request reprint Correlation between cancer location and oncological outcome after radical prostatectomy
    Katsuyoshi Hashine
    Department of Urology, Section of Cancer Prevention and Epidemiology, Clinical Research Center, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Int J Urol 19:855-60. 2012
    ..To examine the association between cancer location, resection margins and oncological outcome in patients undergoing radical prostatectomy...
  3. doi request reprint Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
    Int J Urol 18:813-9. 2011
    ..To examine quality of life (QOL) for 3 years after radical retropubic prostatectomy (RRP) or permanent prostate brachytherapy (PPB) and to determine differences between the two procedures...
  4. doi request reprint Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomy
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 41:571-6. 2011
    ..This study examined the rate of Gleason pattern 5 and the influence of tertiary Gleason pattern 5 on oncological outcomes...
  5. pmc Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:502-8. 2009
    ....
  6. doi request reprint Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 39:381-6. 2009
    ..A previous paper reported favorable results of intra-arterial chemotherapy in combination with radiotherapy for muscle-invasive bladder cancer. The current study will update those results...
  7. doi request reprint A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer
    Katsuyoshi Hashine
    National Hospital Organization Shikoku Cancer Center, 160 Minamiumemoto, Matsuyama 791 0280, Japan
    Jpn J Clin Oncol 38:480-5. 2008
    ..The health-related quality of life (HRQOL) after a radical retropubic prostatectomy (RRP) or a permanent prostate brachytherapy (PPB) was prospectively compared at a single institute...
  8. doi request reprint Health-related quality of life after bladder preservation therapy for muscle invasive bladder cancer
    Katsuyoshi Hashine
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Int J Urol 15:403-6. 2008
    ..To assess health-related quality of life (QOL) of bladder cancer patients following bladder preservation therapy (BPT)...
  9. ncbi request reprint Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama City, Ehime 790 0007, Japan
    Jpn J Clin Oncol 35:655-9. 2005
    ..The present study reports the long-term results of RT combined with hormone therapy for localized and locally advanced prostate cancer...
  10. doi request reprint Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience
    Noriyoshi Miura
    Department of Urology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
    Jpn J Clin Oncol 40:1092-8. 2010
    ..To evaluate the efficacy and toxicity of docetaxel plus prednisolone treatment in Japanese patients with hormone-refractory prostate cancer (HRPC)...
  11. ncbi request reprint [Health-related quality of life after radical prostatectomy or radiotherapy]
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama, Japan
    Nihon Hinyokika Gakkai Zasshi 96:495-502. 2005
    ..We compared general and disease specific health related quality of life (QOL) after surgery and radiotherapy for prostate cancer...
  12. doi request reprint Radiation pneumonitis caused by a migrated brachytherapy seed lodged in the lung
    Noriyoshi Miura
    Department of Urology, Shikoku Cancer Center, Ehime, Japan
    Jpn J Clin Oncol 38:623-5. 2008
    ..The abnormal shadow probably represented radiation pneumonitis. To the best of our knowledge, this is the first report of radiation pneumonitis caused by a migrated brachytherapy seed in the lung...
  13. ncbi request reprint [Correlation of change in prostate-specific antigen and testosterone following withdrawal of androgen ablation after combination of radiation and hormone therapy]
    Katsuyoshi Hashine
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama, Japan
    Nihon Hinyokika Gakkai Zasshi 96:678-84. 2005
    ..We investigated retrospectively that change of serum testosterone and PSA concentrations following withdrawal of androgen ablation after combination of radiation and hormone therapy for prostate cancer...
  14. ncbi request reprint [Primary urothelial carcinoma of the prostate: a case of spread along ducts and into seminal vesicles]
    Noriyoshi Miura
    Department of Urology, National Organization Shikoku Cancer Center
    Nihon Hinyokika Gakkai Zasshi 99:593-6. 2008
    ..pTis pd pN0 M0 Urothelial carcinoma G3 pL0 pV0) He had no adjuvant therapy, he is alive without any evidence of tumor recurrence after surgery...
  15. ncbi request reprint [Results of modified M-VAC chemotherapy for advanced urothelial carcinoma]
    Noriyoshi Miura
    Department of Urology, National Organization Shikoku Cancer Center, Matsuyama, Japan
    Nihon Hinyokika Gakkai Zasshi 98:589-94. 2007
    ..We retrospectively evaluated the efficacy and toxicity of modified M-VAC therapy for locally advanced or metastatic urothelial carcinoma...
  16. doi request reprint Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study
    Yoshiteru Sumiyoshi
    Department of Urology, Shikoku Cancer Center, Ko 16, Minamiumemoto, Mastuyama, Ehime 791 0280, Japan
    Jpn J Clin Oncol 40:967-72. 2010
    ..To assess the efficacy and safety of dietary supplements in patients with early stage prostate cancers who are managed expectantly...
  17. ncbi request reprint Predictor of response to salvage radiotherapy in patients with PSA recurrence after radical prostatectomy: the usefulness of PSA doubling time
    Kousaku Numata
    Department of Urology, Shikoku Cancer Center, 13 Horinouchi, Matuyama, Japan
    Jpn J Clin Oncol 35:256-9. 2005
    ..We assessed predictors of response to salvage radiotherapy (sRT) in patients with prostate-specific antigen (PSA) recurrence after radical prostatectomy...
  18. ncbi request reprint The efficacy of neoadjuvant androgen deprivation therapy as a prostate volume reduction before brachytherapy for clinically localized prostate cancer
    Shin Ebara
    Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700 8558, Japan
    Acta Med Okayama 61:335-40. 2007
    ..A three-month course of the neoadjuvant LH-RH agonist indicated a sufficient volume reduction effectiveness for a large prostate volume...
  19. doi request reprint Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan
    Kazuo Nishimura
    Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1 3 3 Nakamichi, Higashinari ku, Osaka, 537 8511, Japan
    Int J Clin Oncol 18:306-13. 2013
    ..Therefore, this study, ARD6563, was conducted to evaluate the safety of more than ten cycles of docetaxel in metastatic CRPC...
  20. ncbi request reprint [Utility of prostate specific antigen doubling time in repeat biopsy for prostate cancer]
    Koji Azuma
    Department of Urology, Shikoku Cancer Center
    Nihon Hinyokika Gakkai Zasshi 97:42-7. 2006
    ..However, there is not a clear indication for the repeat biopsy. We evaluated the utility of prostate specific antigen doubling time (PSA-DT) as indication for the repeat biopsy...
  21. ncbi request reprint [Two cases of second bladder cancer after radiotherapy for prostate cancer]
    Kousaku Numata
    Department of Urology, Shikoku Cancer Center
    Nihon Hinyokika Gakkai Zasshi 96:466-9. 2005
    ..We report two cases of second bladder cancer after radiotherapy for prostate cancer. It is important to take second cancer into consideration for long-term after the patients are treated with radiotherapy...
  22. ncbi request reprint [A case of hormone-refractory prostate cancer (HRPC) with tumor fever responding to docetaxel plus prednisolone therapy]
    Noriyoshi Miura
    Dept of Urology, Shikoku Cancer Center
    Gan To Kagaku Ryoho 33:841-4. 2006
    ..The patient has survived for twelve months after starting docetaxel plus prednisolone therapy, without serious adverse events...
  23. ncbi request reprint Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer
    Kousaku Numata
    The Department of Urology, Shikoku Cancer Center
    Hinyokika Kiyo 53:99-104. 2007
    ..E-E therapy was considered to be an active oral regimen and well-tolerated for outpatients with hormone-refractory prostate cancer in Japanese patients...
  24. ncbi request reprint The preliminary results of docetaxel-prednisolone combination therapy for the Japanese patients with hormone-refractory prostate cancer
    Kousaku Numata
    The Department of Urology, Shikoku Cancer Center
    Hinyokika Kiyo 53:93-7. 2007
    ..Three patients with nodal metastases and 1 patient with liver metastasis had partial response. Combined docetaxel and prednisolone was shown to be effective and feasible in Japanese patients...